Defining a comprehensive verotype using electronic health records for personalized medicine

被引:50
作者
Boland, Mary Regina [1 ]
Hripcsak, George [1 ]
Shen, Yufeng [1 ,2 ]
Chung, Wendy K. [3 ,4 ,5 ]
Weng, Chunhua [1 ,5 ]
机构
[1] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA
[2] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA
[3] Columbia Univ, Dept Pediat, New York, NY 10032 USA
[4] Columbia Univ, Dept Med, New York, NY 10032 USA
[5] Columbia Univ, Irving Inst Clin & Translat Res, New York, NY 10032 USA
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; GENE-EXPRESSION SIGNATURES; PARKINSONS-DISEASE; NETWORK MEDICINE; BREAST-CANCER; EYE COLOR; SMOKING STATUS; SUBTYPES; ENDOPHENOTYPES; IDENTIFICATION;
D O I
10.1136/amiajnl-2013-001932
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
The burgeoning adoption of electronic health records (EHR) introduces a golden opportunity for studying individual manifestations of myriad diseases, which is called 'EHR phenotyping'. In this paper, we break down this concept by: relating it to phenotype definitions from Johannsen; comparing it to cohort identification and disease subtyping; introducing a new concept called 'verotype' (Latin: vere = true, actually) to represent the 'true' population of similar patients for treatment purposes through the integration of genotype, phenotype, and disease subtype (eg, specific glucose value pattern in patients with diabetes) information; analyzing the value of the 'verotype' concept for personalized medicine; and outlining the potential for using network-based approaches to reverse engineer clinical disease subtypes.
引用
收藏
页码:E232 / E238
页数:7
相关论文
共 91 条
[51]   Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities [J].
Maher, Elizabeth A. ;
Brennan, Cameron ;
Wen, Patrick Y. ;
Durso, Laura ;
Ligon, Keith L. ;
Richardson, Aaron ;
Khatry, Deepak ;
Feng, Bin ;
Sinha, Raktim ;
Louis, David N. ;
Quackenbush, John ;
Black, Peter McL. ;
Chin, Lynda ;
DePinho, Ronald A. .
CANCER RESEARCH, 2006, 66 (23) :11502-11513
[52]   Parkinson's disease subtypes: lost in translation? [J].
Marras, Connie ;
Lang, Anthony .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (04) :409-415
[53]  
McCormick RK, 2007, ALTERN MED REV, V12, P113
[54]  
Mendel G., 1822, Versuche uber Pflanzen-Hybriden, DOI [DOI 10.5962/BHL.TITLE.61004, 10.5962/bhl.title.61004]
[55]  
Mendel G., 1996, EXPT PLANT HYBRIDIZA
[56]   Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis [J].
Murphy, Jennifer ;
Henry, Roland ;
Lomen-Hoerth, Catherine .
ARCHIVES OF NEUROLOGY, 2007, 64 (03) :330-334
[57]  
National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL
[58]   Development and Validation of an Electronic Health Record-Based Chronic Kidney Disease Registry [J].
Navaneethan, Sankar D. ;
Jolly, Stacey E. ;
Schold, Jesse D. ;
Arrigain, Susana ;
Saupe, Well ;
Sharp, John ;
Lyons, Jennifer ;
Simon, James F. ;
Schreiber, Martin J., Jr. ;
Jain, Anil ;
Nally, Joseph V., Jr. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (01) :40-49
[59]   Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction [J].
Nevins, JR ;
Huang, ES ;
Dressman, H ;
Pittman, J ;
Huang, AT ;
West, M .
HUMAN MOLECULAR GENETICS, 2003, 12 :R153-R157
[60]   Genetic determinants of cancer metastasis [J].
Nguyen, Don X. ;
Massague, Joan .
NATURE REVIEWS GENETICS, 2007, 8 (05) :341-352